A new high affinity binding site for suppressor of cytokine signaling-3 on the erythropoietin receptor

European Journal of Biochemistry

Volumn 269, Issue 10, 2002, Pages 2516-2526

  Hörtner, Michael ^a,b   Nielsch, Ulrich ^a,b   Mayr, Lorenz M ^c   Heinrich, Peter C ^b   Haan, Serge ^b  

^a BAYER PHARMA AG   (Germany)

^b RWTH AACHEN UNIVERSITY   (Germany)

^c NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Erythropoietin; SH2 domains; SOCS proteins

Indexed keywords

CYTOKINE INDUCIBLE SH2 CONTAINING PROTEIN 3; ERYTHROPOIETIN; ERYTHROPOIETIN RECEPTOR; JANUS KINASE; PROTEIN; TYROSINE; UNCLASSIFIED DRUG;

AMINO ACID ANALYSIS; ANIMAL CELL; ARTICLE; BINDING AFFINITY; BINDING SITE; CONTROLLED STUDY; MEDICAL LITERATURE; NONHUMAN; PHOSPHORYLATION; PRECIPITATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; SIGNAL TRANSDUCTION; SURFACE PLASMON RESONANCE;

AMINO ACID SEQUENCE; ANIMALS; BINDING SITES; BIOSENSING TECHNIQUES; CELL LINE; CLONING, MOLECULAR; COS CELLS; ESCHERICHIA COLI; HUMANS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTAGENESIS; PHOSPHORYLATION; PROTEIN CONFORMATION; PROTEINS; RECEPTORS, ERYTHROPOIETIN; REPRESSOR PROTEINS; SEQUENCE ALIGNMENT; SRC HOMOLOGY DOMAINS; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TRANSCRIPTION FACTORS; TYROSINE;

ANIMALIA; JANUS;

EID: 0036105755     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1432-1033.2002.02916.x     Document Type: Article

References (51)

1. Structural characterization of human erythropoietin
2. Erythropoietin
3. Signal transduction in the erythropoietin receptor system
4. A novel cytokine-inducible gene CIS encodes an SH2-containing protein that binds to tyrosine-phosphorylated interleukin 3 and erythropoietin receptors
5. A family of cytokine-inducible inhibitors of signalling
6. A new protein containing an SH2 domain that inhibits JAK kinases
7. Structure and function of a new STAT-induced STAT inhibitor
8. Twenty proteins containing a C-terminal SOCS box form five structural classes
9. Cloning and characterization of novel CIS family genes
10. Cloning and functional analysis of new members of STAT induced STAT inhibitor (SSI) family: SSI-2 and SSI-3
11. The conserved SOCS box motif in suppressors of cytokine signaling binds to elongins B and C and may couple bound proteins to proteasomal degradation
12. Thrombopoietin induces an SH2-containing protein, CIS1, which binds to Mpl: Involvement of the ubiquitin proteosome pathway
13. CIS, a cytokine inducible SH1 protein, is a target of the JAK-STAT5 pathway and modulates STAT5 activation
14. Proteasomes regulate erythropoietin receptor and signal transducer and activator of transcription 5 (STAT5) activation. Possible involvement of the ubiquitinated CIS protein
15. Cytokine-inducible SH2 protein-3 (CIS3/SOCS3) inhibits Janus tyrosine kinase by binding through the N-terminal kinase inhibitory region as well as SH2 domain
16. SOCS3 exerts its inhibitory function on interleukin-6 signal transduction through the SHP2 recruitment site of gp130
17. Suppressor of cytokine signaling-3 preferentially binds to the SHP-2-binding site on the shared cytokine receptor subunit gp130
18. SOCS3 mediates feedback inhibition of the leptin receptor via Tyr985
19. Identification of the Y985 and Y1077 motifs as SOCS3 recruitment sites in the murine leptin receptor
20. CIS3/SOCS-3 suppresses erythropoietin (EPO) signaling by binding the EPO receptor and JAK2
21. Kinetics of p56lck and p60src Src homology 2 domain binding to tyrosine-phosphorylated peptides determined by a competition assay or surface plasmon resonance
22. WHAT IF: A molecular modeling and drug design program
23. Protein folding and association: Insights from the interfacial and thermodynamic properties of hydrocarbons
24. Solution structure of the human pp60c-src SH2 domain complexed with a phosphorylated tyrosine pentapeptide
25. Peptide ligands of PP60 (C-SRC) SH2 domains: A thermodynamic and structural study
26. Peptide inhibitors of src SH3-SH2-phosphoprotein interactions
27. Structure of a specific peptide complex of the carboxy-terminal SH2 domain from the p85 alpha subunit of phosphatidylinositol 3-kinase
28. Nuclear magnetic resonance structure of an SH2 domain of phospholipase C-gamma 1 complexed with a high affinity binding peptide
29. Intramolecular interactions of the regulatory domains of the Bcr-Abl kinase reveal a novel control mechanism
30. Crystal structures of peptide complexes of the amino-terminal SH2 domain of the SYP tyrosine phosphatase
31. Basic local alignment search tool
32. Syp associates with gp130 and Janus kinase 2 in response to interleukin-11 in 3T3-L1 mouse preadipocytes
33. Multiple tyrosine residues in the cytosolic domain of the erythropoietin receptor promote activation of STAT5
34. SH2 domains recognize specific phosphopeptide sequences
35. Specific motifs recognized by the SH2 domains of Csk, 3BP2, fps/fes, GRB-2, HCP, SHC, Syk, and Vav
36. Recognition of a high-affinity phosphotyrosyl peptide by the Src homology-2 domain of p56lck
37. Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals
38. Involvement of SH2-containing phosphotyrosine phosphatase Syp in erythropoietin receptor signal transduction pathways
39. JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin
40. Phosphorylation of tyrosine 503 in the erythropoietin receptor (EpR) is essential for binding the P85 subunit of phosphatidyl-inositol (PI) 3-kinase and for EpR-associated PI 3-kinase activity
41. Tyrosine 343 in the erythropoietin receptor positively regulates erythropoietin-induced cell proliferation and Stat5 activation
42. Tyrosine 425 within the activated erythropoietin receptor binds Syp, reduces the erythropoietin required for Syp tyrosine phosphorylation, and promotes mitogenesis
43. Hematopoietic cell phosphatase negatively regulates erythropoietin-induced hemoglobinization in erythroleukemic SKT6 cells
44. SHP1 and SHP2 protein-tyrosine phosphatases associate with βc after interleukin-3-induced receptor tyrosine phosphorylation. Identification of potential binding sites and substrates
45. Direct determination of the sequence recognition requirements of the SH2 domains of SH-PTP2
46. The specificity of the N-terminal SH2 domain of SHP-2 is modified by a single point mutation
47. Determination of the binding specificity of the SH2 domains of protein tyrosine phosphatase SHP-1 through the screening of a combinatorial phosphotyrosyl peptide library
48. Identification of two juxtamembrane autophosphorylation sites in the PDGF beta-receptor; involvement in the interaction with Src family tyrosine kinases
49. Isolation of a src homology 2-containing tyrosine phosphatase
50. Multiple sequence alignment with hierarchical clustering